A new way to help the immune system fight back against cancer

by Kaine Korzekwa,University of Wisconsin-MadisonImmune cells, which look like small, clear circles, next to a small red sphere of neuroblastoma (cancer) cells. When researchers add an anti-neur

Updated on: May 07,2024

A new way to help the immune system fight back against cancer

by Kaine Korzekwa,University of Wisconsin-MadisonImmune cells, which look like small, clear circles, next to a small red sphere of neuroblastoma (cancer) cells. When researchers add an anti-neur

Updated on:May 07,2024

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer

Updated on: April 18,2024

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer

Updated on:April 18,2024

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit

Updated on: June 01,2024

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit

Updated on:June 01,2024

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on: January 25,2024

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on:January 25,2024

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Updated on: January 10,2024

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Updated on:January 10,2024

CAR-T found to be safe and effective on an outpatient basis in community hospitals

byAmerican Society of HematologyCredit: CC0 Public DomainIn the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outp

Updated on: October 26,2024

CAR-T found to be safe and effective on an outpatient basis in community hospitals

byAmerican Society of HematologyCredit: CC0 Public DomainIn the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outp

Updated on:October 26,2024

Advances in multiple myeloma treatment

by Jason Howland, Mayo Clinic News NetworkMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0March is Myeloma Awareness Month. Mul

Updated on: March 20,2024

Advances in multiple myeloma treatment

by Jason Howland, Mayo Clinic News NetworkMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0March is Myeloma Awareness Month. Mul

Updated on:March 20,2024

Researchers discover critical process for how breast cancer spreads in bones

by Brandi Wampler,University of Notre DameScientist Laurie Littlepage works with graduate student Ricardo Romero Moreno in her lab at the Harper Cancer Research Institute. Credit: Barbara Johnst

Updated on: June 19,2024

Researchers discover critical process for how breast cancer spreads in bones

by Brandi Wampler,University of Notre DameScientist Laurie Littlepage works with graduate student Ricardo Romero Moreno in her lab at the Harper Cancer Research Institute. Credit: Barbara Johnst

Updated on:June 19,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on: January 10,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on:January 10,2024

Heterogeneity of liver cancer cells helps explain tumor progression in patients

byThe Mount Sinai HospitalCredit: CC0 Public DomainMany liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect t

Updated on: December 20,2023

Heterogeneity of liver cancer cells helps explain tumor progression in patients

byThe Mount Sinai HospitalCredit: CC0 Public DomainMany liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect t

Updated on:December 20,2023

Study finds novel role of BRCA1 in tumor suppression

by Steven Lee,University of Texas Health Science Center at San AntonioSingle-molecule analysis of BRCA1–BARD1 in BLM- and EXO1-dependent resection. Credit:Nature(2024). DOI: 10.1038/

Updated on: November 11,2024

Study finds novel role of BRCA1 in tumor suppression

by Steven Lee,University of Texas Health Science Center at San AntonioSingle-molecule analysis of BRCA1–BARD1 in BLM- and EXO1-dependent resection. Credit:Nature(2024). DOI: 10.1038/

Updated on:November 11,2024

Researchers devise novel solution to preventing relapse after CAR T-cell therapy

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainEven as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant

Updated on: August 28,2024

Researchers devise novel solution to preventing relapse after CAR T-cell therapy

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainEven as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant

Updated on:August 28,2024